Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
96.81
-4.31 (-4.26%)
At close: Sep 18, 2026, 4:00 PM EDT
96.45
-0.36 (-0.37%)
Pre-market: Sep 21, 2026, 4:02 AM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $5.42 billion as of September 18, 2026. Its market cap has increased by 249.79% in one year.
Market Cap
5.42B
Enterprise Value
4.23B
1-Year Change
249.79%
Ranking
Category
Stock Price
$96.81
ChartMarket Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $5.42B, an increase of 3,222.20%. That is a compound annual growth rate of 219.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.42B | 206.47% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.06B |
| Travere Therapeutics | 5.92B |
| Scholar Rock Holding | 5.69B |
| Ligand Pharmaceuticals | 5.61B |
| Cogent Biosciences | 5.54B |
| PTC Therapeutics | 5.51B |
| CRISPR Therapeutics AG | 5.43B |
| Erasca | 5.24B |